Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Formulation Development Stability Data Evaluation

Posted on By

SOP for Formulation Development Stability Data Evaluation

Evaluating Stability Data in Formulation Development

1) Purpose

The purpose of this SOP is to outline the procedure for evaluating stability data during the formulation development process, ensuring that data integrity is maintained and product stability characteristics are accurately assessed.

2) Scope

This SOP applies to all formulation development projects within the organization, covering the evaluation of stability data for new formulations, changes, or renewals.

3) Responsibilities

The responsibilities for this SOP include:
Formulation Development Team: Evaluating stability data to assess product stability trends and degradation pathways.
Quality Control: Conducting statistical analysis and trending of stability data to determine shelf-life and storage conditions.
Quality Assurance: Reviewing stability data evaluation procedures and ensuring compliance with regulatory standards.
Regulatory Affairs: Using stability data to support regulatory submissions and product registration.

See also  SOP for Formulation Development Change Control Management

4) Procedure

4.1 Data Collection and Compilation

  1. Collect stability data from ongoing stability studies, including results from periodic testing and environmental monitoring.
  2. Compile stability data into organized datasets, ensuring completeness and accuracy of data entries.
  3. Organize data by product batch, stability condition, and testing interval for systematic evaluation.

4.2 Data Analysis and Trending

  1. Analyze stability data using statistical methods and software tools to identify trends and stability characteristics.
  2. Perform trending analysis to monitor changes in product attributes over
time and assess degradation pathways.
  • Generate graphical representations and summary reports of stability data trends for visualization and interpretation.
  • 4.3 Shelf-life Determination

    1. Calculate product shelf-life based on stability data analysis, considering degradation rates, storage conditions, and regulatory requirements.
    2. Document shelf-life determinations and rationale, including supporting stability data and analytical findings.
    3. Review and validate shelf-life calculations with cross-functional teams and regulatory affairs for approval.

    4.4 Reporting and Recommendations

    1. Prepare stability data evaluation reports summarizing findings, trends, and conclusions.
    2. Include recommendations for product storage conditions, labeling requirements, and any necessary adjustments to stability protocols.
    3. Review and approve stability data evaluation reports before submission to regulatory agencies and internal stakeholders.

    5) Abbreviations, if any

    SOP: Standard Operating Procedure

    6) Documents, if any

    Stability Data Sets
    Statistical Analysis Reports
    Shelf-life Determination Reports
    Regulatory Submissions

    7) Reference, if any

    – ICH Q1A(R2): Stability Testing of New Drug Substances and Products
    – FDA Guidance for Industry: Stability Testing of Drug Substances and Products

    8) SOP Version

    Version 1.0

    See also  SOP for Formulation Development Comparative Evaluation Studies
    Formulation Development Tags:API selection SOP, Batch record SOP, Change control SOP, Cleaning Validation SOP, Clinical trial material SOP, Deviation handling SOP, Drug formulation procedure, Equipment Qualification SOP, Excipient selection SOP, Formulation development SOP, Formulation process SOP, GMP SOP, Pharmaceutical SOP, Process Validation SOP, Quality by design SOP, Regulatory submission SOP, Risk assessment SOP, SOP for drug development, SOP for stability testing, SOP guidelines pharmaceutical, SOP pharmaceutical industry, SOP template for formulation, Standard operating procedure formulation, Technology transfer SOP, Validation SOP

    Post navigation

    Previous Post: SOP for Batch Manufacturing Record for Aerosols
    Next Post: SOP for Maintenance of Mixers and Blenders

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version